I would like to make observations regarding our comparables Mindmed and Compass Pathways.
There is some social media commentary tipping some increases for both companies.
This is one example of a few that I have seen recently
Notice Compass Pathway's 52 Week Range?
Both companies appear to be below their historical SP / Market Cap peaks.
Meaning that if an upswing is approaching then there could be plenty of head space for them to move up.
What does this have to do with IHL / IXHL?
We are constantly using them as our benchmark comparables. (Press releases example below and also Psychedelics presentation).
If we were to list on the NASDAQ soon, it could be the "PERFECT STORM" scenario, we might just get some uplift in sentiment and ride the tailwinds of both their moves.
CLICK TO ENLARGE THIS IMAGE
I have converted both Mindmed and Compass Pathways Market Caps to $AUD and used our current shares on issue to calculate where IHL is currently positioned in respect to both.
- IHL could move to AUD $1.18 from its current SP of $0.52c to compare with Mindmed (Potential 2 X ) - After listing
- IHL could move to AUD $2.19 from its current SP of $0.52c to compare with Compass Pathways. (Potential 4 X ) - Between listing and Q1-2 2022
Now the kicker is, that if we ride the tailwinds of both the comparables we could see a substantial increase on these current estimates.
Good luck all